Benzinga
Benzinga
Benzinga
martes, septiembre 29

Encompass Health Corp

EHCNYSE
Trade with Public
Trade with Public
$122.72
-1.30-1.05%
Últ. Act.: Sep 29, 2:25 PM
Dividendo: La fecha límite del dividendo es mañana
Panorámica generalNoticiasPrevisión de beneficiosEventosPrecios objetivoFinanzasSentimientoPropiedadDividendosCompararOpcionesInforme de acciones

Encompass Health Analyst Price Targets

Wall Street analyst price targets and consensus rating for Encompass Health (EHC).

Price Target Range — 11 Quarters

Analyst Consensus — 11 Analysts

1S.Buy
10Buy
Consensus RatingBuy# Analysts11Avg. Consensus PT$130Upside to Avg. PT+5.6%

Rating Trend — Last 9 Months

Recent Analyst Actions

Ver todas las valoraciones →
DateFirmAnalystActionRating ChangePrice Target
Aug 10, 2026TD CowenRyan LangstonPT RaiseBuy$125→$140
Aug 7, 2026UBSA.J. RicePT RaiseBuy$150→$155
More with Benzinga EdgeGet Access

Analyst Ratings News

PRO
TD Cowen Maintains Buy on Encompass Health, Raises Price Target to $140

TD Cowen analyst Ryan Langston maintains Encompass Health (NYSE:EHC) with a Buy and raises the price target from $125 to $140.
Benzinga Newsdesk

PRO
UBS Maintains Buy on Encompass Health, Raises Price Target to $155

UBS analyst A.J. Rice maintains Encompass Health (NYSE:EHC) with a Buy and raises the price target from $150 to $155.
Benzinga Newsdesk

PRO
Truist Securities Maintains Buy on Encompass Health, Raises Price Target to $150

Truist Securities analyst David Macdonald maintains Encompass Health (NYSE:EHC) with a Buy and raises the price target from $140 to $150.
Benzinga Newsdesk

PRO
Barclays Maintains Overweight on Encompass Health, Raises Price Target to $144

Barclays analyst Andrew Mok maintains Encompass Health (NYSE:EHC) with a Overweight and raises the price target from $140 to $144.
Benzinga Newsdesk

PRO
TD Cowen Initiates Coverage On Encompass Health with Buy Rating, Announces Price Target of $125

TD Cowen analyst Ryan Langston initiates coverage on Encompass Health (NYSE:EHC) with a Buy rating and announces Price Target of $125.
Benzinga Newsdesk

PRO
Barclays Maintains Overweight on Encompass Health, Lowers Price Target to $140

Barclays analyst Andrew Mok maintains Encompass Health (NYSE:EHC) with a Overweight and lowers the price target from $153 to $140.
Benzinga Newsdesk

Datos y APIs: APIs de Benzinga · API de noticias de acciones · API de calificaciones de analistas · API de logotipos de empresas

Datos de mercado proporcionados por APIs de Benzinga

Benzinga

Noticias

SOCIO/CONTRIBUIDOR

BENZINGA GLOBAL

© 2026 Benzinga | All Rights Reserved